These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

463 related articles for article (PubMed ID: 24399081)

  • 1. Continuing increased risk of oral/esophageal cancer after allogeneic hematopoietic stem cell transplantation in adults in association with chronic graft-versus-host disease.
    Atsuta Y; Suzuki R; Yamashita T; Fukuda T; Miyamura K; Taniguchi S; Iida H; Uchida T; Ikegame K; Takahashi S; Kato K; Kawa K; Nagamura-Inoue T; Morishima Y; Sakamaki H; Kodera Y;
    Ann Oncol; 2014 Feb; 25(2):435-41. PubMed ID: 24399081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation is Associated with a Reduced Risk of Relapse in Patients with Acute Myeloid Leukemia Who Survived to Day 100 after Transplantation: The Japan Society for Hematopoietic Cell Transplantation Transplantation-related Complication Working Group.
    Takenaka K; Nishida T; Asano-Mori Y; Oshima K; Ohashi K; Mori T; Kanamori H; Miyamura K; Kato C; Kobayashi N; Uchida N; Nakamae H; Ichinohe T; Morishima Y; Suzuki R; Yamaguchi T; Fukuda T
    Biol Blood Marrow Transplant; 2015 Nov; 21(11):2008-16. PubMed ID: 26211985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Secondary solid cancers after allogeneic hematopoietic cell transplantation using busulfan-cyclophosphamide conditioning.
    Majhail NS; Brazauskas R; Rizzo JD; Sobecks RM; Wang Z; Horowitz MM; Bolwell B; Wingard JR; Socie G
    Blood; 2011 Jan; 117(1):316-22. PubMed ID: 20926773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Solid tumors after hematopoietic stem cell transplantation in Japan: incidence, risk factors and prognosis.
    Shimada K; Yokozawa T; Atsuta Y; Kohno A; Maruyama F; Yano K; Taji H; Kitaori K; Goto S; Iida H; Morishima Y; Kodera Y; Naoe T; Morishita Y
    Bone Marrow Transplant; 2005 Jul; 36(2):115-21. PubMed ID: 15908969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Graft-Versus-Host Disease in Adolescents and Young Adults (15-24 Years Old) After Allogeneic Hematopoietic Stem Cell Transplantation for Acute Leukemia in First Complete Remission.
    Vignon M; Andreoli A; Dhédin N; Lengliné E; Masson E; Robin M; Granier C; Larghero J; Schlageter MH; de Latour RP; Socié G; Boissel N
    J Adolesc Young Adult Oncol; 2017 Jun; 6(2):299-306. PubMed ID: 27983886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Donor Epstein-Barr Virus Serostatus on the Incidence of Graft-Versus-Host Disease in Patients With Acute Leukemia After Hematopoietic Stem-Cell Transplantation: A Study From the Acute Leukemia and Infectious Diseases Working Parties of the European Society for Blood and Marrow Transplantation.
    Styczynski J; Tridello G; Gil L; Ljungman P; Hoek J; Iacobelli S; Ward KN; Cordonnier C; Einsele H; Socie G; Milpied N; Veelken H; Chevallier P; Yakoub-Agha I; Maertens J; Blaise D; Cornelissen J; Michallet M; Daguindau E; Petersen E; Passweg J; Greinix H; Duarte RF; Kröger N; Dreger P; Mohty M; Nagler A; Cesaro S
    J Clin Oncol; 2016 Jul; 34(19):2212-20. PubMed ID: 27091716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Influence of graft-versus-host disease on long-term survival of 26 patients with hematologic malignancies after transplantation].
    Lin Q; Dong M; Wang QM; Wen JY; Wu XY
    Ai Zheng; 2006 Oct; 25(10):1261-5. PubMed ID: 17059772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Programmed death 1 ligand (PD-L1) in solid cancers after allogeneic hematopoietic stem cell transplantation: a retrospective analysis by the Nagasaki Transplant Group.
    Kasai S; Itonaga H; Niino D; Miyoshi H; Kato T; Imanishi D; Fujioka M; Furumoto T; Sato S; Sawayama Y; Taguchi J; Imaizumi Y; Hata T; Yoshida S; Moriuchi Y; Ohshima K; Miyazaki Y
    Int J Hematol; 2020 Oct; 112(4):524-534. PubMed ID: 32588395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for late infections after allogeneic hematopoietic stem cell transplantation from a matched related donor.
    Robin M; Porcher R; De Castro Araujo R; de Latour RP; Devergie A; Rocha V; Larghero J; Adès L; Ribaud P; Mary JY; Socié G
    Biol Blood Marrow Transplant; 2007 Nov; 13(11):1304-12. PubMed ID: 17950917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allogeneic hematopoietic cell transplantation without myeloablative conditioning for patients with advanced hematologic malignancies.
    Gürman G; Arat M; Ilhan O; Konuk N; Beksaç M; Celebi H; Ozcan M; Arslan O; Ustün C; Akan H; Uysal A; Koç H
    Cytotherapy; 2001; 3(4):253-60. PubMed ID: 12171713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Donor-recipient killer immunoglobulin like receptor (KIR) genotype matching has a protective effect on chronic graft versus host disease and relapse incidence following HLA-identical sibling hematopoietic stem cell transplantation.
    Sahin U; Dalva K; Gungor F; Ustun C; Beksac M
    Ann Hematol; 2018 Jun; 97(6):1027-1039. PubMed ID: 29549412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High incidence of oral squamous cell carcinoma independent of HPV infection after allogeneic hematopoietic SCT in Taiwan.
    Chen MH; Chang PM; Li WY; Hsiao LT; Hong YC; Liu CY; Gau JP; Liu JH; Chen PM; Chiou TJ; Tzeng CH
    Bone Marrow Transplant; 2011 Apr; 46(4):567-72. PubMed ID: 20622906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Second solid cancers after allogeneic hematopoietic cell transplantation using reduced-intensity conditioning.
    Ringdén O; Brazauskas R; Wang Z; Ahmed I; Atsuta Y; Buchbinder D; Burns LJ; Cahn JY; Duncan C; Hale GA; Halter J; Hayashi RJ; Hsu JW; Jacobsohn DA; Kamble RT; Kamani NR; Kasow KA; Khera N; Lazarus HM; Loren AW; Marks DI; Myers KC; Ramanathan M; Saber W; Savani BN; Schouten HC; Socie G; Sorror ML; Steinberg A; Popat U; Wingard JR; Mattsson J; Majhail NS
    Biol Blood Marrow Transplant; 2014 Nov; 20(11):1777-84. PubMed ID: 25042734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of secondary solid malignancies after allogeneic hematopoietic stem cell transplantation and preventive strategies.
    Adhikari J; Sharma P; Bhatt VR
    Future Oncol; 2015; 11(23):3175-85. PubMed ID: 26551415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secondary solid tumors after allogeneic hematopoietic SCT in Japan.
    Yokota A; Ozawa S; Masanori T; Akiyama H; Ohshima K; Kanda Y; Takahashi S; Mori T; Nakaseko C; Onoda M; Kishi K; Doki N; Aotsuka N; Kanamori H; Maruta A; Sakamaki H; Okamoto S;
    Bone Marrow Transplant; 2012 Jan; 47(1):95-100. PubMed ID: 21358690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Superior GVHD-free, relapse-free survival for G-BM to G-PBSC grafts is associated with higher MDSCs content in allografting for patients with acute leukemia.
    Fan Q; Liu H; Liang X; Yang T; Fan Z; Huang F; Ling Y; Liao X; Xuan L; Xu N; Xu X; Ye J; Liu Q
    J Hematol Oncol; 2017 Jul; 10(1):135. PubMed ID: 28676100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severity of acute gastrointestinal graft-vs-host disease is associated with incidence of bloodstream infection after adult allogeneic hematopoietic stem cell transplantation.
    Modi A; Rybicki L; Majhail NS; Mossad SB
    Transpl Infect Dis; 2020 Feb; 22(1):e13217. PubMed ID: 31769584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secondary malignancies after bone marrow transplantation in adults.
    Lowsky R; Lipton J; Fyles G; Minden M; Meharchand J; Tejpar I; Atkins H; Sutcliffe S; Messner H
    J Clin Oncol; 1994 Oct; 12(10):2187-92. PubMed ID: 7931488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimal dose of rabbit thymoglobulin in conditioning regimens for unmanipulated, haploidentical, hematopoietic stem cell transplantation: Long-term outcomes of a prospective randomized trial.
    Chang YJ; Wang Y; Mo XD; Zhang XH; Xu LP; Yan CH; Chen H; Chen YH; Chen Y; Han W; Wang FR; Wang JZ; Liu KY; Huang XJ
    Cancer; 2017 Aug; 123(15):2881-2892. PubMed ID: 28301690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical analysis of 104 patients with hematological malignancy after allogeneic hemotopoietic stem cell transplantation].
    Chen Y; Xu Y; Zhu Y; Fu G; Liu Y; Peng J; Fu B; He Q; Wu D; Li X; Zhao X; Chen F
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Sep; 36(9):859-64. PubMed ID: 21946205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.